全文获取类型
收费全文 | 323495篇 |
免费 | 19419篇 |
国内免费 | 441篇 |
专业分类
耳鼻咽喉 | 4540篇 |
儿科学 | 11260篇 |
妇产科学 | 10860篇 |
基础医学 | 48202篇 |
口腔科学 | 8042篇 |
临床医学 | 27695篇 |
内科学 | 60781篇 |
皮肤病学 | 6732篇 |
神经病学 | 23685篇 |
特种医学 | 12549篇 |
外国民族医学 | 43篇 |
外科学 | 50115篇 |
综合类 | 8395篇 |
现状与发展 | 1篇 |
一般理论 | 206篇 |
预防医学 | 22970篇 |
眼科学 | 7436篇 |
药学 | 22935篇 |
2篇 | |
中国医学 | 819篇 |
肿瘤学 | 16087篇 |
出版年
2021年 | 2593篇 |
2019年 | 2581篇 |
2018年 | 4020篇 |
2017年 | 2939篇 |
2016年 | 3415篇 |
2015年 | 3878篇 |
2014年 | 5164篇 |
2013年 | 8080篇 |
2012年 | 10176篇 |
2011年 | 10733篇 |
2010年 | 6836篇 |
2009年 | 6060篇 |
2008年 | 9793篇 |
2007年 | 10756篇 |
2006年 | 10577篇 |
2005年 | 10104篇 |
2004年 | 9810篇 |
2003年 | 9153篇 |
2002年 | 8694篇 |
2001年 | 14254篇 |
2000年 | 14592篇 |
1999年 | 12145篇 |
1998年 | 3294篇 |
1997年 | 3045篇 |
1996年 | 2850篇 |
1995年 | 2768篇 |
1994年 | 2545篇 |
1992年 | 8970篇 |
1991年 | 9128篇 |
1990年 | 8880篇 |
1989年 | 8658篇 |
1988年 | 7885篇 |
1987年 | 7606篇 |
1986年 | 7267篇 |
1985年 | 7033篇 |
1984年 | 5168篇 |
1983年 | 4526篇 |
1982年 | 2728篇 |
1979年 | 4835篇 |
1978年 | 3528篇 |
1977年 | 2986篇 |
1976年 | 2733篇 |
1975年 | 3056篇 |
1974年 | 3636篇 |
1973年 | 3605篇 |
1972年 | 3333篇 |
1971年 | 3162篇 |
1970年 | 3028篇 |
1969年 | 2761篇 |
1968年 | 2695篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Kinase alterations are increasingly recognised as oncogenic drivers in mesenchymal tumours. Infantile fibrosarcoma and the related renal tumour, congenital mesoblastic nephroma, were among the first solid tumours shown to harbour recurrent tyrosine kinase fusions, with the canonical ETV6::NTRK3 fusion identified more than 20 years ago. Although targeted testing has long been used in diagnosis, the advent of more robust sequencing techniques has driven the discovery of kinase alterations in an array of mesenchymal tumours. As our ability to identify these genetic alterations has improved, as has our recognition and understanding of the tumours that harbour these alterations. Specifically, this study will focus upon mesenchymal tumours harbouring NTRK or other kinase alterations, including tumours with an infantile fibrosarcoma-like appearance, spindle cell tumours resembling lipofibromatosis or peripheral nerve sheath tumours and those occurring in adults with a fibrosarcoma-like appearance. As publications describing the histology of these tumours increase so, too, do the variety kinase alterations reported, now including NTRK1/2/3, RET, MET, RAF1, BRAF, ALK, EGFR and ABL1 fusions or alterations. To date, these tumours appear locally aggressive and rarely metastatic, without a clear link between traditional features used in histological grading (e.g. mitotic activity, necrosis) and outcome. However, most of these tumours are amenable to new targeted therapies, making their recognition of both diagnostic and therapeutic import. The goal of this study is to review the clinicopathological features of tumours with NTRK and other tyrosine kinase alterations, discuss the most common differential diagnoses and provide recommendations for molecular confirmation with associated treatment implications. 相似文献
2.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
3.
Two Janus-associated kinase inhibitors (JAKi) (initially ruxolitinib and, more recently, fedratinib) have been approved as treatment options for patients who have intermediate-risk and high-risk myelofibrosis (MF), with pivotal trials demonstrating improvements in spleen volume, disease symptoms, and quality of life. At the same time, however, clinical trial experiences with JAKi agents in MF have demonstrated a high frequency of discontinuations because of adverse events or progressive disease. In addition, overall survival benefits and clinical and molecular predictors of response have not been established in this population, for which the disease burden is high and treatment options are limited. Consistently poor outcomes have been documented after JAKi discontinuation, with survival durations after ruxolitinib ranging from 11 to 16 months across several studies. To address such a high unmet therapeutic need, various non-JAKi agents are being actively explored (in combination with ruxolitinib in first-line or salvage settings and/or as monotherapy in JAKi-pretreated patients) in phase 3 clinical trials, including pelabresib (a bromodomain and extraterminal domain inhibitor), navitoclax (a B-cell lymphoma 2/B-cell lymphoma 2-xL inhibitor), parsaclisib (a phosphoinositide 3-kinase inhibitor), navtemadlin (formerly KRT-232; a murine double-minute chromosome 2 inhibitor), and imetelstat (a telomerase inhibitor). The breadth of data expected from these trials will provide insight into the ability of non-JAKi treatments to modify the natural history of MF. 相似文献
4.
5.
6.
7.
8.
9.
10.
O. Ieromina C. J. M. Musters P. M. Bodegom W. J. G. M. Peijnenburg M. G. Vijver 《Ecotoxicology (London, England)》2016,25(6):1170-1180
Analyzing functional species’ characteristics (species traits) that represent physiological, life history and morphological characteristics of species help understanding the impacts of various stressors on aquatic communities at field conditions. This research aimed to study the combined effects of pesticides and other environmental factors (temperature, dissolved oxygen, dissolved organic carbon, floating macrophytes cover, phosphate, nitrite, and nitrate) on the trait modality distribution of aquatic macrofauna communities. To this purpose, a field inventory was performed in a flower bulb growing area of the Netherlands with significant variation in pesticides pressures. Macrofauna community composition, water chemistry parameters and pesticide concentrations in ditches next to flower bulb fields were determined. Trait modalities of nine traits (feeding mode, respiration mode, locomotion type, resistance form, reproduction mode, life stage, voltinism, saprobity, maximum body size) likely to indicate pesticides impacts were analyzed. According to a redundancy analysis, phosphate -and not pesticides- constituted the main factor structuring the trait modality distribution of aquatic macrofauna. The functional composition could be ascribed for 2–4 % to pesticides, and for 3–11 % to phosphate. The lack of trait responses to pesticides may indicate that species may have used alternative strategies to adapt to ambient pesticides stress. Biomass of animals exhibiting trait modalities related to feeding by predation and grazing, presence of diapause form or dormancy, reproduction by free clutches and ovoviviparity, life stage of larvae and pupa, was negatively correlated to the concentration of phosphate. Hence, despite the high pesticide pollution in the area, variation in nutrient-related stressors seems to be the dominant driver of the functional composition of aquatic macrofauna assembly in agricultural ditches. 相似文献